Here, a comparison of gene expression between PLEKHM3 and IDH1 across the GBM tumor revealed the opposite trends, whereby PLEKHM3 was upregulated in the leading edge and downregulated in the cellular tumor (see Supplementary Materials). The gene discussed is PLEKHM3; the disease is glioblastoma.